Premarin Intravenous (conjugated estrogens, USP) for injection
Read this PATIENT INFORMATION which describes the benefit and major risks of your treatment, as well as how and when treatment should be used. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
What is the most important information I should know about Premarin Intravenous (an estrogen mixture)?
|
What is Premarin Intravenous?
Premarin Intravenous is a medicine that contains a mixture of estrogen hormones.
Premarin Intravenous is used to:
Who should not use Premarin Intravenous?
Premarin Intravenous should not be used if you:
Tell your healthcare provider:
What are the possible side effects of Premarin Intravenous?
Premarin Intravenous is for short-term use only. However, the risks associated with oral Premarin treatment should be taken into account.
Side effects are grouped by how serious they are and how often they happen when you are treated.
Serious, but less common side effects include:
Call your healthcare provider right away if you get any of the following warning signs or any other unusual symptoms that concern you:
Less serious, but common side effects include:
These are not all the possible side effects of Premarin. For more information, ask your healthcare provider or pharmacist for advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What can I do to lower my chances of getting a serious side effect with Premarin Intravenous?
General information about the safe and effective use of Premarin Intravenous
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use Premarin Intravenous for conditions for which it was not prescribed. Do not give Premarin Intravenous to other people, even if they have the same symptoms you have. It may harm them. Keep Premarin Intravenous out of the reach of children.
This leaflet provides a summary of the most important information about Premarin Intravenous. If you would like more information, talk with your healthcare provider or pharmacist. You can ask for information about Premarin Intravenous that is written for health professionals. To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What are the ingredients in Premarin IV?
Premarin Intravenous for injection contains a mixture of conjugated estrogens, which are a mixture of sodium estrone sulfate and sodium equilin sulfate and other components including sodium sulfate conjugates: 17α-dihydroequilin, 17α-estradiol, and 17β-dihydroequilin. Premarin Intravenous for injection also contains lactose, sodium citrate, simethicone, and sodium hydroxide or hydrochloric acid in dry form. The reconstituted solution is suitable for intravenous or intramuscular injection.
Each Premarin Intravenous (conjugated estrogens, USP) for injection package provides 25 mg/vial of conjugated estrogens, USP, in dry form for intravenous or intramuscular use.
This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com. |
LAB-0505-6.0
Revised 02/2024
Premarin
Intravenous
(conjugated estrogens, USP) for injection
Rx only
Read this PATIENT INFORMATION which describes the benefit and major risks of your treatment, as well as how and when treatment should be used. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
What is the most important information I should know about Premarin Intravenous (an estrogen mixture)?
|
What is Premarin Intravenous?
Premarin Intravenous is a medicine that contains a mixture of estrogen hormones.
Premarin Intravenous is used to:
Who should not use Premarin Intravenous?
Premarin Intravenous should not be used if you:
Tell your healthcare provider:
What are the possible side effects of Premarin Intravenous?
Premarin Intravenous is for short-term use only. However, the risks associated with oral Premarin treatment should be taken into account.
Side effects are grouped by how serious they are and how often they happen when you are treated.
Serious, but less common side effects include:
Call your healthcare provider right away if you get any of the following warning signs or any other unusual symptoms that concern you:
Less serious, but common side effects include:
These are not all the possible side effects of Premarin. For more information, ask your healthcare provider or pharmacist for advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What can I do to lower my chances of getting a serious side effect with Premarin Intravenous?
General information about the safe and effective use of Premarin Intravenous
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use Premarin Intravenous for conditions for which it was not prescribed. Do not give Premarin Intravenous to other people, even if they have the same symptoms you have. It may harm them. Keep Premarin Intravenous out of the reach of children.
This leaflet provides a summary of the most important information about Premarin Intravenous. If you would like more information, talk with your healthcare provider or pharmacist. You can ask for information about Premarin Intravenous that is written for health professionals. To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What are the ingredients in Premarin IV?
Premarin Intravenous for injection contains a mixture of conjugated estrogens, which are a mixture of sodium estrone sulfate and sodium equilin sulfate and other components including sodium sulfate conjugates: 17α-dihydroequilin, 17α-estradiol, and 17β-dihydroequilin. Premarin Intravenous for injection also contains lactose, sodium citrate, simethicone, and sodium hydroxide or hydrochloric acid in dry form. The reconstituted solution is suitable for intravenous or intramuscular injection.
Each Premarin Intravenous (conjugated estrogens, USP) for injection package provides 25 mg/vial of conjugated estrogens, USP, in dry form for intravenous or intramuscular use.
This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com |
LAB-0518-4.0
Rev 12/2021
Premarin Intravenous (conjugated estrogens, USP) for injection
Read this PATIENT INFORMATION which describes the benefit and major risks of your treatment, as well as how and when treatment should be used. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
What is the most important information I should know about Premarin Intravenous (an estrogen mixture)?
|
What is Premarin Intravenous?
Premarin Intravenous is a medicine that contains a mixture of estrogen hormones.
Premarin Intravenous is used to:
Who should not use Premarin Intravenous?
Premarin Intravenous should not be used if you:
Tell your healthcare provider:
What are the possible side effects of Premarin Intravenous?
Premarin Intravenous is for short-term use only. However, the risks associated with oral Premarin treatment should be taken into account.
Side effects are grouped by how serious they are and how often they happen when you are treated.
Serious, but less common side effects include:
Call your healthcare provider right away if you get any of the following warning signs or any other unusual symptoms that concern you:
Less serious, but common side effects include:
These are not all the possible side effects of Premarin. For more information, ask your healthcare provider or pharmacist for advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What can I do to lower my chances of getting a serious side effect with Premarin Intravenous?
General information about the safe and effective use of Premarin Intravenous
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use Premarin Intravenous for conditions for which it was not prescribed. Do not give Premarin Intravenous to other people, even if they have the same symptoms you have. It may harm them. Keep Premarin Intravenous out of the reach of children.
This leaflet provides a summary of the most important information about Premarin Intravenous. If you would like more information, talk with your healthcare provider or pharmacist. You can ask for information about Premarin Intravenous that is written for health professionals. To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What are the ingredients in Premarin IV?
Premarin Intravenous for injection contains a mixture of conjugated estrogens, which are a mixture of sodium estrone sulfate and sodium equilin sulfate and other components including sodium sulfate conjugates: 17α-dihydroequilin, 17α-estradiol, and 17β-dihydroequilin. Premarin Intravenous for injection also contains lactose, sodium citrate, simethicone, and sodium hydroxide or hydrochloric acid in dry form. The reconstituted solution is suitable for intravenous or intramuscular injection.
Each Premarin Intravenous (conjugated estrogens, USP) for injection package provides 25 mg/vial of conjugated estrogens, USP, in dry form for intravenous or intramuscular use.
This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com. |
LAB-0505-6.0
Revised 02/2024
Premarin
Intravenous
(conjugated estrogens, USP) for injection
Rx only
Read this PATIENT INFORMATION which describes the benefit and major risks of your treatment, as well as how and when treatment should be used. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.
What is the most important information I should know about Premarin Intravenous (an estrogen mixture)?
|
What is Premarin Intravenous?
Premarin Intravenous is a medicine that contains a mixture of estrogen hormones.
Premarin Intravenous is used to:
Who should not use Premarin Intravenous?
Premarin Intravenous should not be used if you:
Tell your healthcare provider:
What are the possible side effects of Premarin Intravenous?
Premarin Intravenous is for short-term use only. However, the risks associated with oral Premarin treatment should be taken into account.
Side effects are grouped by how serious they are and how often they happen when you are treated.
Serious, but less common side effects include:
Call your healthcare provider right away if you get any of the following warning signs or any other unusual symptoms that concern you:
Less serious, but common side effects include:
These are not all the possible side effects of Premarin. For more information, ask your healthcare provider or pharmacist for advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What can I do to lower my chances of getting a serious side effect with Premarin Intravenous?
General information about the safe and effective use of Premarin Intravenous
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use Premarin Intravenous for conditions for which it was not prescribed. Do not give Premarin Intravenous to other people, even if they have the same symptoms you have. It may harm them. Keep Premarin Intravenous out of the reach of children.
This leaflet provides a summary of the most important information about Premarin Intravenous. If you would like more information, talk with your healthcare provider or pharmacist. You can ask for information about Premarin Intravenous that is written for health professionals. To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What are the ingredients in Premarin IV?
Premarin Intravenous for injection contains a mixture of conjugated estrogens, which are a mixture of sodium estrone sulfate and sodium equilin sulfate and other components including sodium sulfate conjugates: 17α-dihydroequilin, 17α-estradiol, and 17β-dihydroequilin. Premarin Intravenous for injection also contains lactose, sodium citrate, simethicone, and sodium hydroxide or hydrochloric acid in dry form. The reconstituted solution is suitable for intravenous or intramuscular injection.
Each Premarin Intravenous (conjugated estrogens, USP) for injection package provides 25 mg/vial of conjugated estrogens, USP, in dry form for intravenous or intramuscular use.
This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com |
LAB-0518-4.0
Rev 12/2021
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.